Financial implications of refugee malaria: The impact of pre-departure presumptive treatment with anti-malarial drugs

American Journal of Tropical Medicine and Hygiene

Volumn 77, Issue 3, 2007, Pages 458-463

  Collinet Adler, Stefan ^b   Stauffer, William M ^a   Boulware, David R ^a   Larsen, Kevin L ^b   Rogers, Tyson B ^a   Williams, David N ^b  

^a UNIVERSITY OF MINNESOTA   (United States)

^b HENNEPIN COUNTY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMALARIAL AGENT; ARTEMETHER PLUS BENFLUMETOL; ATOVAQUONE PLUS PROGUANIL; FANSIDAR;

ADOLESCENT; ARTICLE; CHILD; CONTROLLED STUDY; COST BENEFIT ANALYSIS; COST OF ILLNESS; DRUG COST; FEMALE; HEALTH CARE COST; HUMAN; MAJOR CLINICAL STUDY; MALARIA; MALE; MEDICAL RECORD REVIEW; PREVALENCE; REFUGEE; AFRICA; ECONOMICS; SOUTHEAST ASIA; TIME; UNITED STATES;

AFRICA; ANTIMALARIALS; ASIA, SOUTHEASTERN; FEMALE; HEALTH CARE COSTS; HUMANS; MALARIA; MALE; MINNESOTA; REFUGEES; TIME FACTORS;

EID: 35748936456     PISSN: 00029637     EISSN: None     Source Type: Journal    
DOI: 10.4269/ajtmh.2007.77.458     Document Type: Article

References (30)

1. Breman JG, Alilio MS, Mills A, 2004. Conquering the intolerable burden of malaria: what's new, what's needed: a summary. Am J Trop Med Hyg 71: 1-15.
2. Skarbinski J, James EM, Causer LM, Barber AM, Mali S, Nguyen-Dinh P, Roberts JM, Parise ME, Slutsker L, Newman RD, 2006. Malaria surveillance - United States, 2004. MMWR Surveill Summ 55: 23-37.
3. Eliades MJ, Shah S, Nguyen-Dinh P, Newman RD, Barber AM, Nguyen-Dinh P, Roberts JM, Mali S, Parise ME, Barber AM, Steketee R, 2005. Malaria surveillance - United States, 2003. MMWR Surveill Summ 54: 25-39.
4. Maroushek SR, Aguilar EF, Stauffer W, Abd-Alla MD, 2005. Malaria among refugee children at arrival in the United States. Pediatr Infect Dis J 24: 450-452.
5. Daggy RH, Muegge OJ, Riley WA, 1998. A preliminary survey of the anopheline mosquito fauna of southeastern Minnesota and adjacent Wisconsin areas. Minn Med 81: 41-44.
6. Zucker J, 1996. Changing patterns of autochthonous malaria transmission in the United States: a review of recent outbreaks. Emerg Infect Dis 2: 37-43.
7. Centers for Disease Control and Prevention, Filler SJ, Mac-Arthur JR, Parise M, Wirtz R, Eliades MJ, Dasilva A, Steketee R, 2006. Locally acquired mosquito-transmitted malaria: a guide for investigations in the United States epidemiological investigation. MMWR Morb Mortal Wkly Rep 55: 1-9.
8. Newcombe RG, 1998. Interval estimation for the difference between independent proportions: comparison of eleven methods. Stat Med 17: 873-890.
9. Minnesota Department of Health. Refugee Health Statistics. Accessed October 24, 2006. Available from http://www.health.state.mn.us/divs/ idepc/refugee/stats/index.html
10. Seys SA, Bender JB, 2001. The changing epidemiology of malaria in Minnesota. Emerg Infect Dis 7: 993-995.
11. International Organization for Migration, Migrant Health Department, United States Refugee Program, Medical Program for Sub-Saharan Africa. Pre-Departure Anti-Malarial and Anti-Intestinal Parasitosis Treatment Report. October 1, 2003-September 30, 2004, Fiscal Year 2004 Report, and October 1, 2001-June 2002, Fiscal Year 2002 Report.
12. Centers for Medicare and Medicaid Services. 100% MEDPAR Inpatient Hospital National Data for Fiscal Year 2005. Accessed March 7, 2007. Available from http://www.cms.hhs.gov/MedicareFeeforSvcPartsAB/03_MEDPAR.asp
13. Collins WE, Jeffery GM, 2002. A retrospective examination of sporozoite-induced and trophozoite-induced infections with Plasmodium ovale: development of parasitologic and clinical immunity during primary infection. Am J Trop Med Hyg 66: 492-502.
14. World Health Organization. Procurement of Artemether-Lumefantrine (Coartem®) through WHO. Accessed November 6, 2006. Available from http://www.emro.who.int/rbm/background%20documents/egy04/CoA.pdf
15. Arrow KJ, Gelband H, Jamison DT, 2005. Making antimalarial agents available in Africa. N Engl J Med 352: 333-335.
16. Arrow KJ, Panosian C, Gelband H, 2004. Saving Lives, Buying Time: Economics of Malaria Drugs in an Age of Resistance. Washington, DC: National Academies Press.
17. Pan American Health Organization. Access to Antimalarial Medicines: Improving the Affordability and Financing of Artemisinin-Based Combination Therapies. Accessed October 24, 2006. Available from http://www.paho.org/ English/AD/DPC/CD/mal-afford.htm
18. Wiseman V, Kim M, Mutabingwa T, Whitty CJ, 2006. Cost-effectiveness study of three antimalarial drug combinations in Tanzania. PLoS Med 3: e373.
19. Chanda P, Masiye F, Chitah B, Sipilanyambe N, Hawela M. Banda P, Okorosobo T, 2007. A cost-effectiveness analysis of artemether lumefantrine for treatment of uncomplicated malaria in Zambia. Malar J 6: 21.
20. World Health Organization, 2003: Assessment and Monitoring of Antimalarial Drug Efficacy for the Treatment of Uncomplicated falciparum Malaria. Geneva: World Health Organization.
21. Piola P, Fogg C, Bajunirwe F, Biraro S, Grabdesso F, Ruzagira E, BAbigumira J, Kigozi I, Kiguli J, Kyomuhendo J, Ferradini L, Taylor W, Checchi F, Guthmann JP, 2005. Supervised versus unsupervised intake of six-dose artemether-lumefantrine for treatment of acute, uncomplicated Plasmodium falciparum malaria in Mbarara, Uganda: a randomised trial. Lancet 365: 1467-1473.
22. Chanda P, Hawela M, Kango M, Sipilanyambe N, 2006. Assessment of the therapeutic efficacy of a paediatric formulation of artemether-lumefantrine (Coartesiane) for the treatment of uncomplicated Plasmodium falciparum in children in Zambia. Malar J 5: 75.
23. Bukirwa H, Yeka A, Kamya MR, Talisuna A, Banek K, Bakyaita N, Rwakimari JB, Rosenthal PJ, Wabwire-Mangen F, Dorsey G, Staedke SG, 2006. Artemisinin combination therapies for treatment of uncomplicated malaria in Uganda. PLoS Clin Trials I: e7.
24. Jima D, Tesfaye G, Medhin A, Kebede A, Argaw D, Babaniyi O, 2005. Safety and efficacy of artemether-lumefantrine in the treatment of uncomplicated falciparum malaria in Ethiopia. East Afr Med J 82: 387-390.
25. Mutabingwa TK, Anthony D, Heller A, Hallett R, Ahmed J. Drakeley C, Greenwood BM, Whitty CJ, 2005. Amodiaquine alone, amodiaquine + sulfadoxine-pyrimethamine, amodiaquine + artesunate, and artemether-lumefantrine for outpatient treatment of malaria in Tanzanian children: a four arm randomized effectiveness trial. Lancet 365: 1474-1480.
26. White NJ, 2003. Malaria. Cook GC, Zumla AL, eds. Manson's Tropical Diseases. 21st edition. London: W. B. Saunders, 1206-1210.
27. Stauffer WM, Newberry AM, Cartwright CP, Rosenblatt JE. Hanson K, Sloan L, Tsukayama D, Taylor C, Juni B, 2006. Evaluation of malaria screening in newly arrived refugees to the United States by microscopy and rapid antigen capture enzyme assay (Binax-Now™). Pediatr Infect Dis J 25: 948-950.
28. Kain KC, Harrington MA, Tennyson S, Keystone JS, 1998. Imported malaria: prospective analysis of problems in diagnosis and management. Clin Infect Dis 27: 142-149.
29. Office of Refugee Resettlement Annual Reports to Congress 1997-2004. Accessed December 11, 2006. Available from http://www.acf.hhs.gov/programs/orr/ policy
30. Holtz TH, Kachur SP, MacArthur JR, Roberts JM, Barber AM, Steketee RW, Parise ME, 2001. Malaria surveillance - United States, 1998. MMWR CDC Surveill Summ 50: 1-20.